SEBI’s Cross‑Examination Denial: Natural Justice and Securities Enforcement

Introduction

The Securities and Exchange Board of India’s (SEBI) recent refusal to permit cross-examination in its ongoing investigation into alleged front‑running by Ketan Parekh and an associated market participant, Rohit Salgaocar, has prompted an immediate appeal to the Securities Appellate Tribunal (SAT). According to contemporaneous reporting, Salgaocar — a Singapore‑based participant accused of sharing confidential trade information — seeks a direction that SEBI allow cross‑examination of key witnesses and provide full procedural fairness before adverse findings are framed. The dispute raises core questions about SEBI’s investigatory procedures, the scope of the audi alteram partem principle in quasi‑judicial regulatory enforcement, and the proper balance between efficient market supervision and fair trial‑like protections.

This development is legally important because it tests the limits of procedural fairness in securities regulation, the admissibility and weight of documentary and forensic evidence when cross‑examination is denied, and the appellate oversight role of SAT in safeguarding due process in high‑stakes market‑conduct probes.

Legal Background

SEBI proceeds under a statutory enforcement framework that combines investigative powers with quasi‑judicial decision‑making. Though SEBI is not a court, its proceedings are amenable to the rule of law and foundational administrative law principles. The ancient common law maxim audi alteram partem (hear the other side) underpins modern requirements of procedural fairness, as established in Ridge v Baldwin [1964] AC 40 and developed across Commonwealth jurisprudence. In the corporate context, minority and respondent rights have been shaped by authorities such as Foss v Harbottle (1843) 2 Hare 461 and Ebrahimi v Westbourne Galleries Ltd [1973] AC 360, which illustrate equitable intervention where statutory or majority procedures undermine fairness — analogies that are instructive when regulators wield extensive powers.

Indian administrative jurisprudence similarly requires fairness in quasi‑judicial proceedings; the principles in Maneka Gandhi v Union of India (1978) and subsequent cases require not only notice of charges but, depending on context, an opportunity to test the evidence. The Securities Appellate Tribunal (SAT), and ultimately the courts, have frequently intervened where denial of reasonable opportunity to cross‑examine undermines the integrity of findings in market misconduct cases.

Critical Analysis

The core legal issue is whether SEBI’s denial of cross‑examination constitutes a breach of natural justice sufficient to vitiate its investigative or adjudicative outcome. Regulators often rely on documentary and forensic evidence (trading logs, email metadata, surveillance reports) that may justify determination without viva voce testimony. However, where the contested facts — such as the existence, provenance or interpretation of communications alleged to show collusion or tip‑offs — turn on credibility and disputed factual matrices, the opportunity to cross‑examine is central to testing reliability.

Procedurally, SEBI must weigh competing public‑interest considerations: permitting cross‑examination may reveal sensitive supervisory techniques, compromise whistleblower confidentiality, or prolong investigations. SEBI’s rules and precedents allow procedural adaptations to protect market integrity; Datafin‑type reasoning (recognising the quasi‑public functions of private regulators) and proportionality analysis are relevant when balancing efficiency against individual rights. Nonetheless, the tribunal’s supervisory duty is to ensure that regulatory expediency does not become a cloak for unfairness.

In practice, three lines of analysis will likely determine SAT’s approach. First, what was the nature and sufficiency of untested evidence — are there contested oral statements or merely documents and forensic reconstructions? If the former, denial of cross‑examination risks a miscarriage of justice. Second, did SEBI offer alternative mechanisms to test evidence (for example, allowing written interrogatories, independent expert review, or in‑camera scrutiny)? If adequate substitutes exist and safeguard truth‑finding, denial may be proportionate. Third, prejudice: can the appellant demonstrate that the inability to cross‑examine materially affected SEBI’s ability to reach a fair conclusion? The appellant bears that burden in the first instance, but the tribunal must independently appraise whether any procedural shortcoming is curable or fatal.

Comparative authorities guide this balancing exercise. UK and Commonwealth courts have allowed regulators to undertake streamlined inquiries where evidence is documentary, but have insisted on oral testing where credibility is decisive (see Ridge v Baldwin and principles derived from Ebrahimi on equitable protection in excluded stakeholders). Indian SAT jurisprudence has overturned regulatory findings where denial of cross‑examination prevented adequate adversarial testing, particularly when evidence arose from interviews or informal exchanges rather than incontrovertible records.

Opinion & Outlook

On the facts reported, Salgaocar’s appeal is procedurally well‑founded if SEBI’s case depends substantially on witness testimony or contested inferences that only live testing could expose. If SEBI relied primarily on electronic trade surveillance and immutable logs, the tribunal may be more deferential. Practically, SAT may adopt a middle path: order limited cross‑examination (with protective measures for sensitive material), or require SEBI to disclose fuller particulars and offer alternative testing methods. Such a remedy preserves investigatory efficacy while upholding fairness.

Policywise, this episode highlights a recurring tension in securities enforcement globally: how to reconcile rapid, evidence‑led market policing with due‑process safeguards. Regulators should consider clearer procedural rules on cross‑examination thresholds and protective regimes (redaction, sealed hearings, controlled disclosure) to prevent ad hoc denials that invite appellate scrutiny. Legislative clarification or SEBI rule‑making that sets out when oral examination is required, and how to protect sensitive methods, would reduce litigation and reinforce legitimacy.

Conclusion

SEBI’s refusal to permit cross‑examination in the Parekh‑Salgaocar matter raises substantive questions about procedural fairness in securities enforcement. The SAT’s response will be significant: a ruling favouring greater adversarial testing would strengthen individual rights in regulatory prosecutions; a deferential approach would prioritise investigatory efficiency but risk perceptions of unfairness. Either way, the case underscores the need for transparent procedural frameworks that balance market protection with due‑process guarantees.